Development and characterisation of a 3D multi-cellular in vitro model of normal human breast: a tool for cancer initiation studies
Metrics: PDF 1360 views | HTML 1625 views | ?
Claire E. Nash1,5, Georgia Mavria1, Euan W. Baxter1, Deborah L. Holliday1, Darren C. Tomlinson2, Darren Treanor1,3, Vera Novitskaya4, Fedor Berditchevski4, Andrew M. Hanby1 and Valerie Speirs1
1 Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK
2 Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, UK
3 Leeds Teaching Hospitals NHS Trust, Leeds, UK
4 School of Cancer Sciences, University of Birmingham, Birmingham, UK
5 Current address: The Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
Valerie Speirs, email:
Keywords: 3D cell culture, breast, HER2
Received: January 09, 2015 Accepted: March 18, 2015 Published: April 12, 2015
Multicellular 3-dimensional (3D) in vitro models of normal human breast tissue to study cancer initiation are required. We present a model incorporating three of the major functional cell types of breast, detail the phenotype and document our breast cancer initiation studies. Myoepithelial cells and fibroblasts were isolated and immortalised from breast reduction mammoplasty samples. Tri-cultures containing non-tumorigenic luminal epithelial cells HB2, or HB2 overexpressing different HER proteins, together with myoepithelial cells and fibroblasts were established in collagen I. Phenotype was assessed morphologically and immunohistochemically and compared to normal breast tissue. When all three cell types were present, polarised epithelial structures with lumens and basement membrane production were observed, akin to normal human breast tissue. Overexpression of HER2 or HER2/3 caused a significant increase in size, while HER2 overexpression resulted in development of a DCIS-like phenotype. In summary, we have developed a 3D tri-cellular model of normal human breast, amenable to comparative analysis after genetic manipulation and with potential to dissect the mechanisms behind the early stages of breast cancer initiation.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.